Cargando…

High-Levels of Acquired Drug Resistance in Adult Patients Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in KwaZulu-Natal, South Africa

OBJECTIVE: To determine the frequency and patterns of acquired antiretroviral drug resistance in a rural primary health care programme in South Africa. DESIGN: Cross-sectional study nested within HIV treatment programme. METHODS: Adult (≥18 years) HIV-infected individuals initially treated with a fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Manasa, Justen, Lessells, Richard J., Skingsley, Andrew, Naidu, Kevindra K., Newell, Marie-Louise, McGrath, Nuala, de Oliveira, Tulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749184/
https://www.ncbi.nlm.nih.gov/pubmed/23991055
http://dx.doi.org/10.1371/journal.pone.0072152
_version_ 1782281163578015744
author Manasa, Justen
Lessells, Richard J.
Skingsley, Andrew
Naidu, Kevindra K.
Newell, Marie-Louise
McGrath, Nuala
de Oliveira, Tulio
author_facet Manasa, Justen
Lessells, Richard J.
Skingsley, Andrew
Naidu, Kevindra K.
Newell, Marie-Louise
McGrath, Nuala
de Oliveira, Tulio
author_sort Manasa, Justen
collection PubMed
description OBJECTIVE: To determine the frequency and patterns of acquired antiretroviral drug resistance in a rural primary health care programme in South Africa. DESIGN: Cross-sectional study nested within HIV treatment programme. METHODS: Adult (≥18 years) HIV-infected individuals initially treated with a first-line stavudine- or zidovudine-based antiretroviral therapy (ART) regimen and with evidence of virological failure (one viral load >1000 copies/ml) were enrolled from 17 rural primary health care clinics. Genotypic resistance testing was performed using the in-house SATuRN/Life Technologies system. Sequences were analysed and genotypic susceptibility scores (GSS) for standard second-line regimens were calculated using the Stanford HIVDB 6.0.5 algorithms. RESULTS: A total of 222 adults were successfully genotyped for HIV drug resistance between December 2010 and March 2012. The most common regimens at time of genotype were stavudine, lamivudine and efavirenz (51%); and stavudine, lamivudine and nevirapine (24%). Median duration of ART was 42 months (interquartile range (IQR) 32–53) and median duration of antiretroviral failure was 27 months (IQR 17–40). One hundred and ninety one (86%) had at least one drug resistance mutation. For 34 individuals (15%), the GSS for the standard second-line regimen was <2, suggesting a significantly compromised regimen. In univariate analysis, individuals with a prior nucleoside reverse-transcriptase inhibitor (NRTI) substitution were more likely to have a GSS <2 than those on the same NRTIs throughout (odds ratio (OR) 5.70, 95% confidence interval (CI) 2.60–12.49). CONCLUSIONS: There are high levels of drug resistance in adults with failure of first-line antiretroviral therapy in this rural primary health care programme. Standard second-line regimens could potentially have had reduced efficacy in about one in seven adults involved.
format Online
Article
Text
id pubmed-3749184
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37491842013-08-29 High-Levels of Acquired Drug Resistance in Adult Patients Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in KwaZulu-Natal, South Africa Manasa, Justen Lessells, Richard J. Skingsley, Andrew Naidu, Kevindra K. Newell, Marie-Louise McGrath, Nuala de Oliveira, Tulio PLoS One Research Article OBJECTIVE: To determine the frequency and patterns of acquired antiretroviral drug resistance in a rural primary health care programme in South Africa. DESIGN: Cross-sectional study nested within HIV treatment programme. METHODS: Adult (≥18 years) HIV-infected individuals initially treated with a first-line stavudine- or zidovudine-based antiretroviral therapy (ART) regimen and with evidence of virological failure (one viral load >1000 copies/ml) were enrolled from 17 rural primary health care clinics. Genotypic resistance testing was performed using the in-house SATuRN/Life Technologies system. Sequences were analysed and genotypic susceptibility scores (GSS) for standard second-line regimens were calculated using the Stanford HIVDB 6.0.5 algorithms. RESULTS: A total of 222 adults were successfully genotyped for HIV drug resistance between December 2010 and March 2012. The most common regimens at time of genotype were stavudine, lamivudine and efavirenz (51%); and stavudine, lamivudine and nevirapine (24%). Median duration of ART was 42 months (interquartile range (IQR) 32–53) and median duration of antiretroviral failure was 27 months (IQR 17–40). One hundred and ninety one (86%) had at least one drug resistance mutation. For 34 individuals (15%), the GSS for the standard second-line regimen was <2, suggesting a significantly compromised regimen. In univariate analysis, individuals with a prior nucleoside reverse-transcriptase inhibitor (NRTI) substitution were more likely to have a GSS <2 than those on the same NRTIs throughout (odds ratio (OR) 5.70, 95% confidence interval (CI) 2.60–12.49). CONCLUSIONS: There are high levels of drug resistance in adults with failure of first-line antiretroviral therapy in this rural primary health care programme. Standard second-line regimens could potentially have had reduced efficacy in about one in seven adults involved. Public Library of Science 2013-08-21 /pmc/articles/PMC3749184/ /pubmed/23991055 http://dx.doi.org/10.1371/journal.pone.0072152 Text en © 2013 Manasa et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Manasa, Justen
Lessells, Richard J.
Skingsley, Andrew
Naidu, Kevindra K.
Newell, Marie-Louise
McGrath, Nuala
de Oliveira, Tulio
High-Levels of Acquired Drug Resistance in Adult Patients Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in KwaZulu-Natal, South Africa
title High-Levels of Acquired Drug Resistance in Adult Patients Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in KwaZulu-Natal, South Africa
title_full High-Levels of Acquired Drug Resistance in Adult Patients Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in KwaZulu-Natal, South Africa
title_fullStr High-Levels of Acquired Drug Resistance in Adult Patients Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in KwaZulu-Natal, South Africa
title_full_unstemmed High-Levels of Acquired Drug Resistance in Adult Patients Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in KwaZulu-Natal, South Africa
title_short High-Levels of Acquired Drug Resistance in Adult Patients Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in KwaZulu-Natal, South Africa
title_sort high-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural hiv treatment programme in kwazulu-natal, south africa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749184/
https://www.ncbi.nlm.nih.gov/pubmed/23991055
http://dx.doi.org/10.1371/journal.pone.0072152
work_keys_str_mv AT manasajusten highlevelsofacquireddrugresistanceinadultpatientsfailingfirstlineantiretroviraltherapyinaruralhivtreatmentprogrammeinkwazulunatalsouthafrica
AT lessellsrichardj highlevelsofacquireddrugresistanceinadultpatientsfailingfirstlineantiretroviraltherapyinaruralhivtreatmentprogrammeinkwazulunatalsouthafrica
AT skingsleyandrew highlevelsofacquireddrugresistanceinadultpatientsfailingfirstlineantiretroviraltherapyinaruralhivtreatmentprogrammeinkwazulunatalsouthafrica
AT naidukevindrak highlevelsofacquireddrugresistanceinadultpatientsfailingfirstlineantiretroviraltherapyinaruralhivtreatmentprogrammeinkwazulunatalsouthafrica
AT newellmarielouise highlevelsofacquireddrugresistanceinadultpatientsfailingfirstlineantiretroviraltherapyinaruralhivtreatmentprogrammeinkwazulunatalsouthafrica
AT mcgrathnuala highlevelsofacquireddrugresistanceinadultpatientsfailingfirstlineantiretroviraltherapyinaruralhivtreatmentprogrammeinkwazulunatalsouthafrica
AT deoliveiratulio highlevelsofacquireddrugresistanceinadultpatientsfailingfirstlineantiretroviraltherapyinaruralhivtreatmentprogrammeinkwazulunatalsouthafrica
AT highlevelsofacquireddrugresistanceinadultpatientsfailingfirstlineantiretroviraltherapyinaruralhivtreatmentprogrammeinkwazulunatalsouthafrica